EP2667868 - BENDAMUSTINE FORMULATIONS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 27.11.2015 Database last updated on 19.10.2024 | Most recent event Tooltip | 17.03.2017 | Change - priority | published on 19.04.2017 [2017/16] | Applicant(s) | For all designated states Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3 Banjara Hills Hyderabad 500 034 Andhra Pradesh / IN | For all designated states Dr. Reddy's Laboratories Inc. 200 Somerset Corporate Boulevard, 7th Floor Bridgewater, NJ 08807 / US | [2013/49] | Inventor(s) | 01 /
KOCHERLAKOTA, Chandrasekhar Plot No. 50, BHEL Enclave Akbar Road Tarbund Secunderabad, 500 009 Andhra Pradesh / IN | 02 /
SINGH, Tarun S/O Dr. C. P. Singh 16A Teachers Coony Near Peer, Champur District Binjor, 246761, Uttar Pradesh / IN | 03 /
BANDA, Nagaraju c/o B. Ganga Raju 693, Vivekananda Nagar Kukatpally Hyderabad, 502 072, Andhra Pradesh / IN | 04 /
KHATI, Nirmal Shivashray, Indraprastha Colony Near New ITI, P. O. Manpur Paschim Daharaiya, Rampur Road Haldwani District Nainital, 263 139, Uttarakhand / IN | 05 /
SHARMA, Sachin Vill. Trind P. O. Nagrota Bagwan District Kangra, 176 047, Himachal Pradesh / IN | 06 /
VURE, Prasad Plot No. 29 H. No. 32-80/29, Devi Nagar Colony R. K. Puram Secunderabad, 500 556, Andhra Pradesh / IN | 07 /
MULUPURU, Aparna Flat No. S-2, B Block, Brindavan Apartments Chikoti Gardens Begumpet Hyderabad, 500 016, Andhra Pradesh / IN | 08 /
VAYA, Navin 796 Shastri Nagar Dadabari Kota, 324 009, Rajasthan / IN | 09 /
CHARKHA, Amit Anil Saikripa, Samarthwadi Bhamtipura Wardha, 442 001, Maharashtra / IN | [2013/49] | Representative(s) | Bates, Philip Ian Reddie & Grose LLP The White Chapel Building 10 Whitechapel High Street London E1 8QS / GB | [N/P] |
Former [2013/49] | Bates, Philip Ian Reddie & Grose LLP 16 Theobalds Road London WC1X 8PL / GB | Application number, filing date | 12738849.4 | 25.01.2012 | WO2012US22561 | Priority number, date | IN2011CHE241 | 25.01.2011 Original published format: IN 241CH2011 | US201161453796P | 17.03.2011 Original published format: US 201161453796 P | [2017/16] |
Former [2013/49] | IN2011CHE0241 | 25.01.2011 | |
US201161453796P | 17.03.2011 | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2012103226 | Date: | 02.08.2012 | Language: | EN | [2012/31] | Type: | A2 Application without search report | No.: | EP2667868 | Date: | 04.12.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.08.2012 takes the place of the publication of the European patent application. | [2013/49] | Search report(s) | International search report - published on: | KR | 24.01.2013 | (Supplementary) European search report - dispatched on: | EP | 10.11.2014 | Classification | IPC: | A61K31/4184, A61P35/02, A61K9/19, A61K47/26 | [2014/49] | CPC: |
A61K31/4184 (EP,US);
A61K47/26 (EP,US);
A61K9/19 (EP,US);
A61P35/02 (EP)
|
Former IPC [2013/49] | A61K31/4184, C07D235/16, A61P35/02 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/49] | Title | German: | BENDAMUSTINFORMULIERUNGEN | [2013/49] | English: | BENDAMUSTINE FORMULATIONS | [2013/49] | French: | FORMULATIONS DE BENDAMUSTINE | [2013/49] | Entry into regional phase | 20.08.2013 | National basic fee paid | 20.08.2013 | Search fee paid | 20.08.2013 | Designation fee(s) paid | 20.08.2013 | Examination fee paid | Examination procedure | 20.08.2013 | Examination requested [2013/49] | 07.04.2014 | Loss of particular rights, legal effect: Claims | 15.05.2014 | Despatch of communication of loss of particular rights: Claims {1} | 09.06.2015 | Application deemed to be withdrawn, date of legal effect [2015/53] | 20.07.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/53] | Fees paid | Renewal fee | 04.11.2013 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.01.2015 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [IP]WO2011103150 (CEPHALON INC [US], et al) [IP] 1-15 * sentence 9 - sentence 11; example . *; | [A] - FDA, "Highlights of prescribing information TREANDA", (2008), URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022303lbl.pdf, (20141029), XP002731807 [A] 1-15 * the whole document * | International search | [X]US2006159713 (BRITTAIN JASON E [US], et al); | [A]US2007116729 (PALEPU NAGESWARA R [US]); | [X]US2009264488 (COOPER MARTIN IAN [GB], et al) |